Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    MEDTECH PRODS

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2MALLINCKRODT HOSP

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    MALLINCKRODT HOSP

    ACETAMINOPHEN

    arrow
    Discovery Europe
    Not Confirmed

    MALLINCKRODT HOSP

    Australia
    arrow
    Discovery Europe
    Not Confirmed

    Patent Expiration Date : 2028-11-13

    ACETAMINOPHEN

    US Patent Number : 10383834

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 22450

    Patent Use Code : U-2262

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2028-11-13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    MALLINCKRODT HOSP

    ACETAMINOPHEN

    arrow
    Discovery Europe
    Not Confirmed

    MALLINCKRODT HOSP

    Australia
    arrow
    Discovery Europe
    Not Confirmed

    Patent Expiration Date : 2028-11-13

    ACETAMINOPHEN

    US Patent Number : 10383834

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 22450

    Patent Use Code : U-2621

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2028-11-13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF